We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+39.96%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$1.48B
AUM Growth
+$386M
Cap. Flow
+$89.6M
Cap. Flow %
6.06%
Top 10 Hldgs %
43.47%
Holding
92
New
20
Increased
28
Reduced
19
Closed
16

Top Buys

Rank Stock Value
1
ALHC icon
Alignment Healthcare
ALHC
+$17.8M
2
CYTK icon
Cytokinetics
CYTK
+$16.5M
3
VERA icon
Vera Therapeutics
VERA
+$12.7M
4
CNC icon
Centene
CNC
+$12.1M
5
ISRG icon
Intuitive Surgical
ISRG
+$12M

Top Sells

Rank Stock Value
1
MLYS icon
Mineralys Therapeutics
MLYS
+$26M
2
BSX icon
Boston Scientific
BSX
+$25.9M
3
DXCM icon
DexCom
DXCM
+$17.5M
4
GEHC icon
GE HealthCare
GEHC
+$14.8M
5
EHC icon
Encompass Health
EHC
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 92.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
26
Elevance Health
ELV
$84.7B
$16.2M 1.09%
50,000
-10,000
-17% -$3.11M
ELAN icon
27
Elanco Animal Health
ELAN
$11.4B
$16.1M 1.09%
800,000
+450,000
+129% +$7.54M
EW icon
28
Edwards Lifesciences
EW
$54B
$15.6M 1.05%
200,000
– –
LLY icon
29
Eli Lilly
LLY
$1.08T
$15.3M 1.03%
20,000
-5,000
-20% -$3.72M
CVS icon
30
CVS Health
CVS
$120B
$15.1M 1.02%
200,000
-50,000
-20% -$3.43M
TARS icon
31
Tarsus Pharmaceuticals
TARS
$3.05B
$14.9M 1.01%
250,000
+50,000
+25% +$2.46M
INSM icon
32
PUT
Insmed
INSM
$29B
$14.4M 0.97%
+100,000
New +$12.3M
MDT icon
33
Medtronic
MDT
$116B
$14.3M 0.97%
150,000
-50,000
-25% -$4.6M
CNC icon
34
Centene
CNC
$32.1B
$14.3M 0.97%
+400,000
New +$12.1M
DOCS icon
35
Doximity
DOCS
$4.65B
$13.2M 0.89%
+180,000
New +$11.7M
PFE icon
36
Pfizer
PFE
$152B
$12.7M 0.86%
500,000
-200,000
-29% -$4.94M
PEN icon
37
Penumbra
PEN
$12.9B
$12.7M 0.86%
50,000
+10,000
+25% +$2.52M
ACLX
38
DELISTED
Arcellx
ACLX
$12.3M 0.83%
+150,000
New +$10.8M
ASND icon
39
Ascendis Pharma A/S
ASND
$16.7B
$11.9M 0.81%
+60,000
New +$11.2M
FMS icon
40
Fresenius Medical Care
FMS
$12.7B
$11.8M 0.8%
450,000
-300,000
-40% -$7.71M
MCK icon
41
McKesson
MCK
$105B
$11.6M 0.78%
15,000
+5,000
+50% +$3.52M
A icon
42
Agilent Technologies
A
$42.2B
$11.6M 0.78%
90,000
+40,000
+80% +$4.83M
ROIV icon
43
Roivant Sciences
ROIV
$25.5B
$11.3M 0.77%
750,000
+150,000
+25% +$1.86M
NVST icon
44
Envista
NVST
$4.58B
$11.2M 0.76%
+550,000
New +$11.3M
ISRG icon
45
Intuitive Surgical
ISRG
$142B
$11.2M 0.76%
+25,000
New +$12M
IRTC icon
46
iRhythm Holdings
IRTC
$4.02B
$11.2M 0.76%
65,000
+25,000
+63% +$3.97M
EXAS
47
DELISTED
Exact Sciences
EXAS
$10.9M 0.74%
200,000
+100,000
+100% +$5M
UPB
48
Upstream Bio Inc
UPB
$386M
$10.8M 0.73%
+575,000
New +$8.93M
ORIC icon
49
Oric Pharmaceuticals
ORIC
$1.42B
$10.8M 0.73%
900,000
-350,000
-28% -$3.68M
RGNX icon
50
Regenxbio
RGNX
$703M
$10.6M 0.72%
1,100,000
+400,000
+57% +$3.54M
1
2
3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, Integral Health Asset Management held 92 positions worth $1.48B, up 35% from $1.09B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Integral Health Asset Management deployed $89.6M of net new capital in Q3 2025, opening 20 new positions and adding to 28 existing holdings. Its largest new stake was Centene: 400,000 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 98% a quarter earlier.

On the sell side, the largest reduction was Mineralys Therapeutics, an estimated $26M trimmed.

  • Integral Health Asset Management's largest Q3 2025 buy was Centene: 400,000 shares worth $14.3M.
  • Integral Health Asset Management added most to Alignment Healthcare in Q3 2025, an estimated $17.8M increase.
  • Integral Health Asset Management's biggest Q3 2025 reduction was Mineralys Therapeutics, cutting an estimated $26M.
  • Integral Health Asset Management fully exited DexCom in Q3 2025, selling an estimated $17.5M.
  • Integral Health Asset Management's ten largest holdings make up 43% of its $1.48B portfolio in Q3 2025.
  • Integral Health Asset Management opened 20 new positions and closed 16 in Q3 2025.
  • Integral Health Asset Management's portfolio value rose 35% quarter-over-quarter to $1.48B.

Based on Integral Health Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.